Skip to search formSkip to main contentSkip to account menu

tautomycetin

Known as: (17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxo-nonadeca-16,18-dien-2-yl) 3-hydroxy-3-(4-methyl-2,5-dioxo-3-furyl)-propanoate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Tautomycetin (TMC) is a linear polyketide metabolite produced by Streptomyces sp. CK4412 that has been reported to possess… 
2013
2013
Tautomycetin (TMC), originally isolated from Streptomyces griseochromogenes, has been suggested as a potential drug retaining… 
2010
2010
The biosynthetic gene cluster for tautomycetin (TTN), a highly potent and selective protein phosphatase (PP) inhibitor isolated… 
2009
2009
Comparative transcriptome analysis has revealed several acidic pH shock-induced genes presumably involved with stimulation of… 
2008
2008
Tautomycetin (TMC) is a novel activated T-cell-specific immunosuppressive compound with a unique structure, containing an ester… 
2008
2008
TNFalpha activated NF-kappaB and associated regulatory factors including IKK are strongly implicated in a variety of… 
2006
2006
Tautomycetin is an antifungal antibiotic retaining potent immunosuppressive function. We have identified the roles of… 
Highly Cited
2002
Highly Cited
2002
Tautomycetin (TMC) was identified as an immunosuppressor of activated T cells. Inhibition of T cell proliferation with TMC was… 
1992
1992
TNFalpha activated NF-kappaB and associated regulatory factors including IKK are strongly implicated in a variety of… 
1990
1990
The chemical structure of tautomycetin (C33H50O10) was determined by chemical degradation and spectroscopic evidence…